EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Hereditary Angioedema: A Review of the Current and Evolving Treatment Landscape

Stephen D Betschel, Aleena Banerji, Paula J Busse, Danny M Cohn, Markus Magerl

The Journal of Allergy and Clinical Immunology: In Practice · 2023

DOI: 10.1016/j.jaip.2023.04.017 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2023. Verfasst von Stephen D Betschel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Angioedemas, Hereditary, Angioedema. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Takeda Canada, BioMarin Pharmaceutical.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hereditary angioedema (HAE) is a rare disease characterized by sudden and often unprovoked episodes of swelling that can be potentially life-threatening when it involves the upper airway. The treatment options for both acute episodes of HAE and LTP, used to minimize the frequency and severity of angioedema attacks, were limited historically to very few options, had considerable side effects, and/or had considerable burden of treatment. Fortunately, through the elucidation of the pathophysiology of HAE, the development of newer targeted therapies has been possible both for acute therapy and long-term prophylaxis and even more are on the horizon. Because of the rapid development of these therapies, it can be challenging for clinicians to keep abreast of newer and developing treatments for HAE. This review article will outline the current and potential future treatments for HAE. It will also highlight important considerations when treating special HAE patient populations including women and pediatric patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angioedemas, HereditaryAngioedemaHumansFemaleChildComplement C1 Inhibitor Protein

Stichwörter der Autor:innen

Hereditary angioedema

Substanzen

Complement C1 Inhibitor Protein

Autor:innen und Institutionen

  • Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Department of Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, Mass. Electronic address: abanerji@mgh.harvard.edu.
  • Division of Allergy and Clinical Immunology, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Department of Vascular Medicine, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Amsterdam, the Netherlands.
  • Institute of Allergology, Charité-Universitätsmedizin Berlin (corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin), Berlin, Germany; Department of Immunology and Allergology, Fraunhofer Insti…

Förderung

  • Takeda Canada
  • BioMarin Pharmaceutical

Zitieren

APA

Betschel, S. D., Banerji, A., Busse, P. J., Cohn, D. M., & Magerl, M. (2023). Hereditary Angioedema: A Review of the Current and Evolving Treatment Landscape. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2023.04.017

Vancouver

Betschel SD, Banerji A, Busse PJ, Cohn DM, Magerl M. Hereditary Angioedema: A Review of the Current and Evolving Treatment Landscape. The Journal of Allergy and Clinical Immunology: In Practice. 2023. doi:10.1016/j.jaip.2023.04.017

BibTeX
@article{Betschel2023,
  author = {Betschel, Stephen D and Banerji, Aleena and Busse, Paula J and Cohn, Danny M and Magerl, Markus},
  title = {Hereditary Angioedema: A Review of the Current and Evolving Treatment Landscape},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2023},
  doi = {10.1016/j.jaip.2023.04.017}
}
Kostenlos starten →